Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Refractory B Lymphoblastic Lymphoma
Baltimore, Maryland
Refractory B Lymphoblastic Lymphoma Clinical Trials in Baltimore, Maryland
1 recruiting
Baltimore, Maryland
Showing
1–1
of
1
trials
Recruiting
Phase 2
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia
Refractory B Acute Lymphoblastic Leukemia
Recurrent B Lymphoblastic Lymphoma
+1 more
Children's Oncology Group
80 enrolled
157 locations
NCT02981628
Feedback